Femasys (FEMY) Asset Writedowns and Impairment (2021 - 2025)
Femasys' (FEMY) quarterly Asset Writedowns and Impairment came in at -$5000.0 in Q1 2025, down 600.0% YoY from $1000.0 in Q1 2024, and down 350.0% on a QoQ basis from $2000.0 in Q4 2024.
Femasys (FEMY) Asset Writedowns and Impairment (2021 - 2025) Analysis & Trends
Femasys (FEMY) has 5 years of Asset Writedowns and Impairment data on file, last reported at -$5000.0 in Q1 2025.
- Quarterly Asset Writedowns and Impairment fell 600.0% year-over-year to -$5000.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $2000.0 (up 100.0% YoY) and the FY2024 annual result came in at $8000.0, changed N/A from the prior year.
- Asset Writedowns and Impairment slipped to -$5000.0 in Q1 2025, from $2000.0 in the prior quarter.
- In the past five years, Asset Writedowns and Impairment ranged from a high of $3202.0 in Q3 2023 to a low of -$5000.0 in Q1 2025.
- A 5-year average of $587.69 and a median of $1000.0 in 2024 frame the typical range for Asset Writedowns and Impairment.
- The widest YoY moves for Asset Writedowns and Impairment: up 785.0% in 2023, down 1757.33% in 2023.
- Tracing FEMY's Asset Writedowns and Impairment over 5 years: stood at $540.0 in 2021, then sank by 44.44% to $300.0 in 2022, then plunged by 1757.33% to -$4972.0 in 2023, then jumped by 140.23% to $2000.0 in 2024, then plunged by 350.0% to -$5000.0 in 2025.
- The last three Asset Writedowns and Impairment figures came in at -$5000.0 (Q1 2025), $2000.0 (Q4 2024), and $3170.0 (Q3 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn |
| 10 | Femasys | 9.97 Mn | 8.53 Mn | 189,391.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Dec 31, 2024 | 2,000.00 |
| Sep 30, 2024 | 3,170.00 |
| Sep 30, 2024 | 3,170.00 |
| Jun 30, 2024 | 1,830.00 |
| Jun 30, 2024 | 1,830.00 |
| Mar 31, 2024 | 1,000.00 |
| Mar 31, 2024 | 1,000.00 |
| Dec 31, 2023 | -4,972.00 |
| Dec 31, 2023 | -4,972.00 |
| Sep 30, 2023 | 3,202.00 |
| Sep 30, 2023 | 3,202.00 |
| Jun 30, 2023 | 1,770.00 |
| Jun 30, 2023 | 1,770.00 |
| Dec 31, 2022 | 300.00 |
| Dec 31, 2022 | 300.00 |
| Sep 30, 2022 | 900.00 |
| Sep 30, 2022 | 900.00 |